On November 20, 2023, TC Biopharm (Holdings) Plc (NASDAQ: TCBP) opened at $0.524, higher 9.47% from the last session. During the day, the shares moved up to $0.59 and dropped to $0.49 before settling in for the closing price of $0.47. Price fluctuations for TCBP have ranged from $0.36 to $96.10 over the past 52 weeks.
Company’s average yearly earnings per share was noted 97.70% at the time writing. With a float of $0.22 million, this company’s outstanding shares have now reached $0.35 million.
Considering the fact that the conglomerate employs 77 people, you should pay attention to its efficiency factor.
TC Biopharm (Holdings) Plc (TCBP) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of TC Biopharm (Holdings) Plc is 11.74%, while institutional ownership is 12.40%. The most recent insider transaction that took place on Nov 30, was worth 350,000. In this transaction 10% Owner of this company bought 70,000 shares at a rate of $5.00, taking the stock ownership to the 70,000 shares. Before that another transaction happened on Nov 30, when Company’s 10% Owner bought 70,000 for $5.00, making the entire transaction worth $350,000. This insider now owns 382,963 shares in total.
TC Biopharm (Holdings) Plc (TCBP) Recent Fiscal highlights
This company achieved a net margin of -36.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 97.70% per share during the next fiscal year.
TC Biopharm (Holdings) Plc (NASDAQ: TCBP) Trading Performance Indicators
Check out the current performance indicators for TC Biopharm (Holdings) Plc (TCBP). In the past quarter, the stock posted a quick ratio of 1.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -17.05
Technical Analysis of TC Biopharm (Holdings) Plc (TCBP)
Compared to the last year’s volume of 0.69 million, its volume of 1.06 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 63.44%. Additionally, its Average True Range was 0.68.
During the past 100 days, TC Biopharm (Holdings) Plc’s (TCBP) raw stochastic average was set at 29.23%, which indicates a significant decrease from 70.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 144.26% in the past 14 days, which was higher than the 116.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4206, while its 200-day Moving Average is $1.3506. Nevertheless, the first resistance level for the watch stands at $0.5767 in the near term. At $0.6333, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6767. If the price goes on to break the first support level at $0.4767, it is likely to go to the next support level at $0.4333. Now, if the price goes above the second support level, the third support stands at $0.3767.
TC Biopharm (Holdings) Plc (NASDAQ: TCBP) Key Stats
There are currently 950K shares outstanding in the company with a market cap of 5.12 million. Presently, the company’s annual sales total 4,760 K according to its annual income of -1,720 K. Last quarter, the company’s sales amounted to 495 K and its income totaled -3,900 K.